Concepedia

Peter Gedeck

PG

40

Publications

2.5K

Citations

27

H-Index

1995

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (Singapore)

Friedrich-Alexander-Universität Erlangen-Nürnberg

Novartis (United Kingdom)

Peter Gedeck is an author at Novartis (Switzerland) specializing in medicine, engineering, and pharmacology.

Top concepts

MedicineEngineeringDrug DiscoveryNatural SciencesPharmacologyChemistryComputational ChemistryBiochemistryData ScienceBiophysics

Publications per year

1995–2019

40

Publications

40

Comparability of Mixed IC50 Data – A Statistical Analysis

Tuomo Kalliokoski, Christian Krämer, Anna Vulpetti et al. · PLoS ONE · 2013 · 305 citations · Full text

Engineering, Hit Identification, Lead Identification +22

QSAR − How Good Is It in Practice? Comparison of Descriptor Sets on an Unbiased Cross Section of Corporate Data Sets

Peter Gedeck, Bernhard Rohde, Christian Bartels · Journal of Chemical Information and Modeling · 2006 · 220 citations

Cross Section, Engineering, Machine Learning +19

The Experimental Uncertainty of Heterogeneous Public <i>K</i><sub>i</sub> Data

Christian Krämer, Tuomo Kalliokoski, Peter Gedeck et al. · Journal of Medicinal Chemistry · 2012 · 219 citations

Uncertainty (Quantum Physics), Engineering, Data Science +15

Reviews in Computational Chemistry, Vol. 8

Peter Gedeck · Journal of Molecular Modeling · 1997 · 193 citations

Engineering, Natural Sciences, Computational Chemistry +3

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski et al. · Nature · 2017 · 191 citations · Full text

Pharmacology, Medicine, Pathology +1

Rows per page

1–5 of 40